The overall goal of this protocol is to evaluate the biodistribution of [18F]MNI-1054 as a LSD1 targeted radiopharmaceutical. The specific objectives are:~To determine the radiation dosimetry of [18F]MNI-1054~To assess the safety and tolerability of a single dose of [18F]MNI-1054
The overall goal of this protocol is to evaluate the biodistribution of [18F]MNI-1054 as a LSD1 targeted radiopharmaceutical.